Multi Sample Osmometer Improves Testing Efficiency
|
By LabMedica International staff writers Posted on 03 Aug 2016 |

Image: The OsmoPRO multi-sample osmometer for automated testing (Photo courtesy of Advanced Instruments).
A novel 20-position micro sample osmometer improves laboratory efficiency, productivity, and workflow by reducing sample turn-around time.
The OsmoPRO Multi-Sample Osmometer for automated osmolality testing is designed to analyze a variety of complex aqueous mixtures, including blood, serum, plasma, urine, cell culture media, drug formulations, and biological cell therapies, using a small, 20 μL sample size. Samples can be analyzed one at a time, or batch processed depending on workflow demands. Timesaving features include an intuitive touch screen, automated processing, and the ability to run unattended. The device also uses the freezing point depression method to deliver results in just two minutes.
The OsmoPRO can be used in a variety of laboratory applications including clinical diagnostics, formulation development, bioprocess monitoring and process control, industrial, environmental, and finished product quality control. An integrated barcode scanner provides positive sample identification to reduce transcription errors, with data management and transfer handled via the on-board printer or by exporting the data using an ethernet connection and multiple USB ports. The OsmoPRO multi-sample osmometer, a product of Advanced Instruments (Norwood, MA, USA), will be presented at AACC 2016.
“OsmoPRO incorporates more than 60 years of applied technology and expertise from Advanced Instruments, the industry leader in the field of osmometry,” said Peter Costas, vice president of sales and marketing at Advanced Instruments. “OsmoPRO replaces the Advanced Model 2020 osmometer, which has been an extremely popular and reliable osmometer used in thousands of laboratories worldwide, and represents Advanced Instruments commitment to quality and innovation in the field of osmometry”.
Osmometers are used for measuring the osmotic strength of a solution, colloid, or compound, or determining the molecular weight of unknown compounds and polymers. Several techniques can be used, including vapor pressure depression to determine the concentration of osmotically active particles; determining the osmotic pressure of a solution separated from pure solvent by a semipermeable membrane; and freezing point depression to determine osmotically active compounds in a solution.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Advanced Instruments
American Association for Clinical Chemistry
The OsmoPRO Multi-Sample Osmometer for automated osmolality testing is designed to analyze a variety of complex aqueous mixtures, including blood, serum, plasma, urine, cell culture media, drug formulations, and biological cell therapies, using a small, 20 μL sample size. Samples can be analyzed one at a time, or batch processed depending on workflow demands. Timesaving features include an intuitive touch screen, automated processing, and the ability to run unattended. The device also uses the freezing point depression method to deliver results in just two minutes.
The OsmoPRO can be used in a variety of laboratory applications including clinical diagnostics, formulation development, bioprocess monitoring and process control, industrial, environmental, and finished product quality control. An integrated barcode scanner provides positive sample identification to reduce transcription errors, with data management and transfer handled via the on-board printer or by exporting the data using an ethernet connection and multiple USB ports. The OsmoPRO multi-sample osmometer, a product of Advanced Instruments (Norwood, MA, USA), will be presented at AACC 2016.
“OsmoPRO incorporates more than 60 years of applied technology and expertise from Advanced Instruments, the industry leader in the field of osmometry,” said Peter Costas, vice president of sales and marketing at Advanced Instruments. “OsmoPRO replaces the Advanced Model 2020 osmometer, which has been an extremely popular and reliable osmometer used in thousands of laboratories worldwide, and represents Advanced Instruments commitment to quality and innovation in the field of osmometry”.
Osmometers are used for measuring the osmotic strength of a solution, colloid, or compound, or determining the molecular weight of unknown compounds and polymers. Several techniques can be used, including vapor pressure depression to determine the concentration of osmotically active particles; determining the osmotic pressure of a solution separated from pure solvent by a semipermeable membrane; and freezing point depression to determine osmotically active compounds in a solution.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Advanced Instruments
American Association for Clinical Chemistry
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Adhesives Research to Present Hydrophilic Adhesive Technologies
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read more
AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
Diagnosing the cause of age-related cognitive symptoms remains challenging because clinical presentations of neurodegenerative diseases often overlap, and multiple pathologies can co-occur... Read moreMolecular Diagnostics
view channel
cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more
Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes
Respiratory viruses such as influenza A/B and SARS‑CoV‑2 continue to burden urgent care and emergency settings, where rapid, reliable differentiation guides therapy and infection control.... Read moreHematology
view channel
AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
Bone marrow aspirate examination is central to diagnosing and monitoring blood cancers and other serious hematologic diseases, yet the process in many laboratories remains manual and highly dependent on... Read more
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read moreImmunology
view channel
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read morePathology
view channel
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read more
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer is typically guided by recurrence risk and population-level averages rather than patient-specific benefit. However, existing clinicopathologic... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channelGlobal Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more








